Enhancement of return to independent living status with a growth hormone secretagogue
US6194402A · kind A · utility
15Cited by
6References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 31, 1999 |
| Grant date | Feb 27, 2001 |
| Priority date | — |
| Expiry date | Aug 31, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/27
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A growth hormone secretagogue is useful for enhancing the return of patients to independent living status following acute deconditioning such as that which may result from immobilization, surgery, or major injury such as hip fracture.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.